Flex Pharma Reports Year End 2015 Financial Results

Go back to Flex Pharma Reports Year End 2015 Financial Results

Flex Pharma (FLKS) Tops Q4 EPS by 5c

March 8, 2016 7:04 AM EST

Flex Pharma (NASDAQ: FLKS) reported Q4 EPS of ($0.51), $0.05 better than the analyst estimate of ($0.56).

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

... More